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Abstract
Harlequin Ichthyosis is a severe skin disease caused by mutations in the human gene
encoding ABCA12. Here, we characterize a novel mutation in intron 29 of the mouse
Abca12 gene that leads to the loss of a 5’ splice donor site and truncation of the Abca12
RNA transcript. Homozygous mutants of this smooth skin or smsk allele die perinatally with
shiny translucent skin, typical of animal models of Harlequin Ichthyosis. Characterization of
smskmutant skin showed that the delivery of glucosylceramides and CORNEODESMOSIN
was defective, while ultrastructural analysis revealed abnormal lamellar bodies and the
absence of lipid lamellae in smsk epidermis. Unexpectedly, mutant stratum corneum
remained intact when subjected to harsh chemical dissociation procedures. Moreover, both
KALLIKREIN 5 and -7 were drastically decreased, with retention of desmoplakin in mutant
SC. In cultured wild type keratinocytes, both KALLIKREIN 5 and -7 colocalized with cer-
amide metabolites following calcium-induced differentiation. Reducing the intracellular lev-
els of glucosylceramide with a glucosylceramide synthase inhibitor resulted in decreased
secretion of KALLIKREIN proteases by wild type keratinocytes, but not by smskmutant ker-
atinocytes. Together, these findings suggest an essential role for ABCA12 in transferring
not only lipids, which are required for the formation of multilamellar structures in the stratum
corneum, but also proteolytic enzymes that are required for normal desquamation. Smsk
mutant mice recapitulate many of the pathological features of HI and can be used to explore
novel topical therapies against a potentially lethal and debilitating neonatal disease.
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Introduction
Harlequin Ichthyosis (HI, OMIM 242500) is one of the most severe recessive congenital skin dis-
eases [1–3]. Affected infants develop large, armor-like skin plates separated by deep fissures.
Although these skin plates are hard and thick, they are ineffective as a permeability barrier [4].
The hard skin plates constrict body movements, and cause the malformation of ears, eyelids and
lips during development [5]. The barrier defects and the deep fissures lead to excessive water and
heat loss, and render HI patients more susceptible to environmental insults [6]. Even with
improvements during intensive perinatal care, many HI infants die soon after birth [7, 8].
All cases of HI caused to date have been associated with mutations in ABCA12 (ATP-bind-
ing cassette (ABC), sub-family A, member 12), a gene that belongs to the ABC family of trans-
porters [9–12]. The A subfamily of the ABC transporters consists of at least eleven members in
humans and mice that are important for transporting various lipids in different tissues. More-
over, mutations of other A type subfamily members (e.g., ABCA1, 3, and 4) have been impli-
cated in several human diseases with abnormal lipid metabolism [13–15]. The known roles of
ABCA proteins in lipid transport have led to a focus on abnormal lipid metabolism in the epi-
dermis as the primary cause of the HI pathology [16, 17].
Studies of human HI patients have revealed approximately 50 independentABCA12mutations
that can lead to HI. These occur throughout the coding region and often result in protein trunca-
tion due to nonsense mutations, although there are also a number of splice site mutations that affect
exon usage, as well as missense mutations. Importantly, mutations in ABCA12 have been associated
with Type II Lamellar Ichthyosis (LI 2, OMIM 601277) and Non-Bullous Congenital Ichthyosiform
Erythroderma (NBCIE, OMIM 242100) [18–20], both less severe forms of the disease.
Several lines of evidence have led to the hypothesis that ABCA12 plays a critical role in
packaging glucosylceramides (GlcCer) into intracellular lamellar bodies (LBs) that are then
delivered to the interstices of the stratum corneum (SC), allowing for “cargo” lipids to be pro-
cessed and incorporated into the intercellular lipid barrier. First, ABCA12 colocalizes with LBs
[21]. Second, LBs appear abnormal and there is a the lack of extra-cellular lipid lamellae in HI
skin [16, 22]. Third, GlcCer is mislocalized in HI keratinocytes in vitro, which can be corrected
by ABCA12 gene transfer [10]. This hypothesis has gained further support from several Abca12
mutant mouse models that recapitulate many of the pathological features of HI, including
strikingly thickened SC, skin fissures, trans-epidermal water loss, limb contractures, and facial
malformation [23–25]. Lipid analysis of the skin from these mice suggests that ABCA12 trans-
porter is critical for GlcCer trafficking during epidermal barrier formation [23, 25].
Here we describe a new recessive mouse model, “smooth skin” or “smsk”, derived from an
N-ethyl-N-nitrosourea (ENU) mutagenesis screen that displays many of the hallmarks of HI.
Analysis of this Abca12smsk/smsk strain further reveals that the ABCA12 transporter is involved
in two critical processes essential for normal desquamation: the transfer of lipids and the trans-
port of proteolytic enzymes to the SC. Lastly, we show that topical delivery of exogenous KAL-
LIKREIN (KLK) proteases to the smskmouse model can increase desquamation and
ameliorate the HI phenotype. This suggests a potential new treatment for human HI patients.
Results
Identification of a recessive mutant mouse line with skin defects
Following a recessive screen based on ENU-treated founder C57BL/6J male mice and a three-
generation cross we identified a mutant line we named smooth skin (smsk), in which 25% of the
offspring (120 of 498) presented with a pronounced perinatal lethal skin phenotype. Develop-
ment of the defective skin condition was studied by examining smsk homozygous mutants at
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different embryonic stages. Mutant embryos showed a normal appearance at E14.5, but at
E16.5 mutants developed a partial absence of normal skin folds around the trunk and limbs,
and by E18.5 the mutant embryos developed a taut, thick skin and limb contractures (Fig 1A).
Newborn mutant pups died within a few hours after birth, and appeared severely dehydrated
with dry cracking skin (data not shown).
We performed toluidine dye penetration assays on embryos at E18.5 when the skin barrier
normally becomes fully functional, just prior to birth, to test whether the permeability of smsk
skin was altered. The mutant skins stained entirely blue, whereas skins of wild type (WT) litter-
mates were impenetrable to the dye (Fig 1B), demonstrating a defective skin barrier underlying
the smsk phenotype. Histologically, skin sections from smsk embryos at E18.5 lacked the loose
pattern of the normal SC, revealing instead a hyperkeratotic epidermis. Transmission electron
microscopy (TEM) showed that mutant SC contained twice as many layers as WT skin
(16 ± 1.8 vs. 8 ± 2.6 (Mutant vs WT, Avg ± SD), p<0.0003). Although all epidermal cell layers
were present in mutant epidermis, there was an expansion of the granular layer, a reduction in
the size of the spinous layer, and a disorganized basal layer (Fig 1C). Despite the gross morpho-
logical skin defects, the hair follicles appeared to develop and differentiate normally.
Genetic Mapping Indicates that smsk is caused by a splice site mutation
in Abca12
Genetic mapping of the smskmutation was initially accomplished by outcrossing the ENU-
mutagenized C57BL/6J founder male onto a WT 129S1/SvImJ background. Analysis of MIT
microsatellite markers followed by deep sequencing revealed that the mutation responsible for
the skin phenotype was in a 5’ splice donor site in intron 29 of Abca12 (Fig 2A). The mutation
causes a thymine to guanine transversion at the second nucleotide of the downstream intron
and converts the consensus donor sequence ‘AGGT’ to ‘AGGG’ (Fig 2A). Analysis and
sequencing of the smsk transcript between the region corresponding to exons 28 and 30 in the
WT controls confirmed the deletion of exon 29 (Fig 2B and 2C). The skipping of exon 29 in
the smsk allele would predict an in-frame deletion of 73 amino acids resulting in a truncated
protein lacking a critical part of the first ATP binding cassette beginning at amino acid 1388
(Fig 2D and 2E). Hereafter, the smskmutant line is referred to as Abca12smsk/smsk.
Defective glucosylceramide trafficking, abnormal lamellar body and
intercellular lipid lamellar structure in Abca12smsk/smsk epidermis
The connection between the smskmutation and the lipid trafficking defects typifying HI were fur-
ther explored using histological and ultrastructural analyses. Ceramides (Cer) in the SC are mainly
derived from GlcCer and are the major components of the lamellar layers between the corneo-
cytes. GlcCer molecules are synthesized by differentiating keratinocytes, packaged into LBs, and
secreted into the intercellular space between the granular layer and cornified layer, where they are
enzymatically processed into Cer and included in the lipid lamellae [26–29]. Immunofluorescence
was employed to co-examine the distribution of GlcCer and Cer (GlcCer/Cer) in mutant skin. In
WT epidermis, GlcCer/Cer staining was continuous in all epidermal cell layers, with strongest
staining observed in the SC. However, mutant epidermis showed weaker GlcCer/Cer staining in
both the basal and suprabasal layers, and was strikingly reduced in the SC (Fig 3A), consistent
with defective GlcCer trafficking in Abca12smsk/smsk epidermis.
TEM was performed to examine the gross appearance of the SC and lipid trafficking defect
at an ultrastructural level. As shown in Fig 3B, WT skin showed normal lipid secretion and dis-
appearance of corneodesmosomes (CDs) above the stratum granulosum (SG) and first two lay-
ers of SC, whereas smsk skin showed the collapse of adjacent cells and persistence of CDs.
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Enumeration of CDs revealed significantly higher density (number of CDs/length of corneo-
cyte membrane) in both the lower and upper layers of the smsk SC (S1 Fig). Moreover, incom-
plete cornification was evident in mutant SC with cells appearing transitional. Multi-lamellar
Fig 1. Skin abnormalities in smskmice. (a) E18.5 smsk embryos display a shiny, tight and thickened skin phenotype
with limb contractures. (b) Smsk E18.5 embryos have epidermal barrier defects as demonstrated by a toluidine dye
penetration assay. (c) Histology of mutant E18.5 embryonic skin demonstrates severe hyperkeratosis with more than 16
layers of corneocytes in the SC and disorganized architecture in other epidermal layers. Bar for a and b = 2.5 mm. Bar for
c = 25 μm. Epidermal layers: SB = stratum basale; SS = stratum spinosum; SG = stratum granulosum; SC = stratum
corneum.
doi:10.1371/journal.pone.0161465.g001
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structures were apparent in the spaces between the corneocytes and cornified and granular lay-
ers of WT skin, but these structures were not observed in Abca12smsk/smsk epidermis (Fig 3C).
The granular cells from mutants were superficially similar to controls, with numerous struc-
tures resembling LBs observed in the cytoplasm or fused to the cell membrane (Fig 3D). How-
ever, no multilayered cargo was observed in the vesicles of Abca12smsk/smsk granular cells. The
corneocyte lipid envelope appeared normal in Abca12smsk/smsk epidermis, a finding in common
with HI patient pathology [28–30]. Overall, our data indicate that defects in lipid trafficking in
the SG-SC layers are associated with the loss of exon 29 from the smsk transcript.
Terminal differentiation is deregulated in Abca12smsk/smsk epidermis
To study overall development of the skin, the expression of representative differentiation mark-
ers and cell proliferation were examined in the epidermis of E18.5 embryos. Staining for the
basal layer marker KERATIN 14 (KRT14) showed a comparable distribution pattern in both
WT and mutant epidermis (Fig 4A). Staining for LORICRIN and REPETIN also displayed sim-
ilar distribution patterns in both WT and mutant epidermis (data not shown). We also deter-
mined that epidermal proliferation, measured using an in utero 5-bromo-2'-deoxyuridine
(BrdU) incorporation assay, was similar in the basal layer of WT and mutant fetal epidermis
(Fig 4A). In contrast, a clear difference between WT and mutant skin was apparent when using
an antibody that recognizes a C-terminal epitope of KRT1 that is cleaved during maturation
[31]. In WT skin, immunostaining was only observed in the suprabasal layers and was not seen
in the SC as the epitope is cleaved off during terminal maturation. In contrast, immunoreactiv-
ity in mutant skin extended from the spinous layers to the SC (Fig 4B). Furthermore, we
observed a marked induction of the “stress” keratin, KRT16, in smsk epidermis, whereas
KRT16 was undetectable in WT skin (Fig 4C). Furthermore, staining of KRT6, which is nor-
mally only expressed in the developing hair follicles at this age [32], was increased in the supra-
basal layers of the Abca12Smsk/Smsk epidermis (not shown). Induction of both KRT6 and -16
indicate that smsk skin was under “stress” conditions. Parakeratosis was also evident in the SC
of Abca12smsk/smsk mice (Fig 4C). Taken together our results are indicative of aberrant differen-
tiation caused by the smskmutation, a similar pathology to that observed in HI patients.
Retention of desmosomal/corneodesmosomal components in
Abca12smsk/smsk epidermis
To define the functional consequences of the smskmutation, we performed a boiling dissocia-
tion assay of the SC. WT SC typically dissociates into individual cornified envelopes (CEs)
upon boiling in extraction buffer (Fig 5A). In stark contrast, the SC of ABCA12 mutant skin
never disassociated and instead floated as a homogenous sheet (Fig 5A). Under microscopic
examination, corneocytes in mutant epidermis were still tightly attached to each other even
after prolonged attempts to separate them (Fig 5A). As indicated above, the reduction of lipid
Fig 2. A mutation in Abca12 is associated with the smsk phenotype. (a). The recessive mutation responsible for the skin phenotype of smsk
was mapped by linkage analysis to a region containing the Abca12 genomic locus. Genomic DNA sequencing showed that the wild type (WT) 5’
splice donor site “GT” in the 29th intron of Abca12 on the C57/B6 background was mutated to “GG” in the phenotypic mice. Non-phenotypic
carrier mice contained both “GT” and “GG” alleles. (b) Alignment of WT and mutant Abca12 cDNA sequences showed that the splice site
mutation resulted in a skipping of exon 29 in the mutant Abca12mRNA and would produce an in-frame deletion of amino acids encoded by exon
29 in the mutant protein. (c) The cDNA fragments of Abca12 encompassing exon 28 to 31 were amplified by RT-PCR from skin RNA of WT
(764bp) and smskmutant (HI, 545bp) mice. The bands were resolved by agarose gel electrophoresis. (d) In silico translation analysis predicted
that the smskmutation results in a truncated protein with an in-frame fusion between amino acid sequences encoded by exons 28 (green) and
30 (red). The normal sequence encoded by the splicing of exon 28 to exon 29 is shown in black. (e) Alternative splicing skips exon 29, leading to
an in-frame deletion of 73 amino acids from the first ATP-binding domain of ABCA12.
doi:10.1371/journal.pone.0161465.g002
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secretion from SG keratinocytes in smsk skin likely contributed to the tight packing of mutant
corneocytes. Another contribution to the observed corneocyte adherence in smsk SC could be
biochemical changes in the desmosomal components of the Abca12smsk/smsk epidermis. As des-
mosomes mature into CDs, CORNEODESMOSIN (CDSN) further strengthens the adhesion
of adjacent corneocytes. Subsequently, these desmosomal components are gradually degraded
by desquamatory proteases, such as KLK5, and -7 [33, 34]. In WT SC, the detection of the ‘fish-
net’ pattern for DESMOPLAKIN, a desmosomal protein that connects desmocadherins to
intracellular keratin fibrils [35, 36], was restricted to the granular layers. In contrast, in
Abca12smsk/smsk epidermis the DESMOPLAKIN staining extended to all layers of the thickened
SC (Fig 5B). The desmosomal and corneodesmosomal cadherin DESMOCOLLIN3 (DSC3)
was less apparent in smsk SC, whereas DESMOGLEIN 1/2 (DSG) levels and distribution
remained similar to WT epidermis (Fig 5C and 5D). Staining for CDSN, which is delivered to
the SC interstices by LBs [37], was markedly decreased in the SG of the mutant skin compared
to WT littermates (Fig 5E). This mirrored the reduction observed in GlcCer/Cer levels (Fig
3A). The reduction of CDSN staining by immunohistochemistry was not due to reduced tran-
scription as its mRNA abundance was elevated in smskmutant skin (S2 Fig). Interestingly,
Abca12mRNA levels were also upregulated in smsk skin, which may indicate feedback regula-
tion of its expression in response to deficiency of its cellular function (S2 Fig). We also stained
for INVOLUCRIN (IVL), a component of the cornified lipid envelope. IVL staining was simi-
lar in the SG of WT and mutant, but it was also detected throughout the SC layers of mutant
skin and appeared membrane associated, suggestive of altered processing (Fig 5F).
Fig 3. Defects in lipid accumulation in the stratum corneum of Abca12smsk/smsk mutant mice. (a) Immunofluorescence staining for
glucosylceramide/ceramide (GlcCer/Cer) showed localization throughout the suprabasal layers of WT epidermis, whereas reduced levels
were detected in the SC (thin dashed lines) of E18.5 Abca12smsk/smsk epidermis. Bar = 25 μm. (b) Transmission electron microscopy (TEM)
shows the disappearance of corneodesmosomes (CDs) (white arrows) above the SG-SC interface in WTmice, whereas CDs are retained
in smsk SC. Bars = 200 nm and 500 nm respectively. (c) TEM pictures show the presence of normal intercellular lipid lamellae (arrow) at the
junctions between SG and SC layers in the WT epidermis but not in the mutant epidermis. Bars = 200 nm. (d) Ultrastructural analysis shows
that lamellar bodies (LBs) in WT epidermis were loaded with lipid lamellae and fused with the surface of granular cells (arrow). LBs in
mutant epidermis had no lamellar cargo, but fusion with the granular cell membrane appeared normal. Bars = 200 nm.
doi:10.1371/journal.pone.0161465.g003
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Fig 4. Abca12smsk/smsk displays defects in terminal differentiation. (a). Cell proliferation rates were similar in both WT and smsk
embryonic epidermis as determined by in utero incorporation of 5-bromo-2'-deoxyuridine (BrdU). Sections were stained with an anti-BrdU
antibody (green) and counterstained with KERATIN 14 (KRT14) (red). Note that no difference in the expression pattern of KRT14 was
observed in either WT or mutant epidermis. Bars = 25 μm. (b) Keratinocytes in Abca12smsk/smskmutant skin undergo abnormal terminal
differentiation as demonstrated by scattered pattern of KRT1 (red) detection in the SC. Bars = 50 μm. (c) KRT16 (red) was ectopically
expressed in the interfollicular suprabasal keratinocytes of Abca12smsk/smsk epidermis, whereas it was undetecteable in theWT
epidermis. Furthermore, the retention of nuclei (parakeratosis) in the SC is observable in smskmutant skin. Bar = 25 μm.
doi:10.1371/journal.pone.0161465.g004
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KALLIKREIN proteases are not delivered to the stratum corneum in
Abca12smsk/smsk epidermis
The severe hyperkeratosis, retention of corneocytes, and reduced detection of CDSN suggested
that there could be a desquamatory defect in mutant epidermis. KLK5, -7 and -14 are major
serine proteases that mediate desquamation and are secreted into the extracellular spaces at the
junction between the granular and cornified layers, where their enzymatic activities are initi-
ated by self-cleavage of pro-KLK5. The activated KLKs then digest CD components that bind
the corneocytes together, thus allowing these cellular structures to be shed [33, 36, 38]. We
examined the distribution of both KLK5 and -7 in the epidermis using immunofluorescence
staining. Compared to WT in which staining could be observed in all epidermal layers, the dis-
tribution of both KLK5 and -7 decreased significantly from the upper granular layers through
all levels of the SC in Abca12smsk/smsk mutants (Fig 5G and 5H). Similar to Abca12 and Cdsn,
Klk7mRNA abundance was increased in mutant skin (S2 Fig), indicating that decreased
immunodetection of KLK7 was not due to reduced transcription.
Fig 5. Enhanced adhesion of cornified envelopes in the Abca12smsk/smsk epidermis. E18.5 skin pieces from both WT and Abca12smsk/smsk
embryos were boiled in cornified envelope (CE) extraction buffer. (a) WT skin pieces dissociated after boiling for 10 minutes, resulting in the
dissolution of skin into individual CEs (Left panels). The mutant skins were never completely dissolved, even after extended hours of boiling. No
individual CEs from the mutant skin were evident (Right panels). Bars = 5 mm and 20 μm, respectively. (b-f) Skin sections of both WT and
Abca12smsk/smsk embryos showed (b) expression of DESMOPLAKIN (DSP), a component of both desmosomes and CDs, persisting throughout the
thickened SC of the smsk epidermis; (c) a minor decrease in DESMOCOLLIN (DSC3) staining in the smsk SC; (d) no change in DESMOGLEIN
(DSC) 1&2 staining in mutant skin versusWT; (e) reduced SC localization of CORNEODESMOSIN (CDSN) in mutant skin; (f) and INVOLUCRIN
(IVL) staining throughout the SC of mutant mice but reduced levels in lower layers compared to WT skin. (g-h) Immunofluorescence detection of
KLK5 and -7 revealed their presence in all layers of theWT epidermis with prominent expression observed at the junction between granular and
cornified layers. In contrast, KLK staining was reduced in the smsk SC. Bars = 25 μm.
doi:10.1371/journal.pone.0161465.g005
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KALLIKREIN proteins and labeled ceramide metabolites colocalize in
differentiating keratinocytes
The concomitant defects in GlcCer transport and decreased detection of desquamation
enzymes in the smskmutant epidermis prompted us to explore whether ABCA12 directly assis-
ted in the transfer of both lipids and KLKs. To test this hypothesis, we followed the fate of fluo-
rescently labelled KLKs and Cer in cultured mouse primary keratinocytes induced to
differentiate by elevated Ca++ levels. Fluorescent Cer is metabolized into fluorescent sphingo-
myelin and GlcCer, thus allowing us to study lipid trafficking [39–42]. Under elevated Ca++
conditions, extensive colocalization of both KLK5 and -7 with labeled Cer metabolites was
observed, indicating that these SC components are cotransported (S3A and S3B Fig). The fail-
ure to deliver both GlcCer and the major desquamation enzymes to the SC in our HI mouse
model suggested that KLK trafficking could be dependent on GlcCer transport by ABCA12. To
test this possibility, we used a highly-specific GlcCer synthase inhibitor, d,l-threo-1-phenyl-
2-decanoylamino-3-morpholino-1-propanolhydro- chloride (PDMP), which has been shown
to decrease the intracellular levels of GlcCer in both human and mouse keratinocytes in vitro
[43, 44]. In WT keratinocytes, the levels and the enzymatic activities of KLK5 and -7 were
markedly decreased in the culture media after PDMP treatment (Fig 6), suggesting that de
novo glucoceramide production is necessary for proper secretion of KLKs. Intriguingly, the
secretion and activity of KLKs from Abca12smsk/smsk keratinocytes was significantly lower
under all culture conditions and was not enhanced by Ca++ treatment, presumably due to the
inability of the ABCA12 mutant protein to transfer GlcCer (Fig 6A and 6B).
Abca12smsk/smskmouse skin as a model for therapeutic discovery
The severe desquamatory defects seen in the epidermis of our smskmodel suggested a possible
new treatment strategy to alleviate the hyperkeratosis in HI skin, namely by the topical applica-
tion of KLK enzymes. To test the feasibility of this strategy we utilized a whole skin graft system
as Abca12smsk/smsk mutant mice die shortly after birth. To accomplish these experiments, we
grafted either WT or mutant E18.5 skin onto the back of immunocompromised mice. The
grafted smsk skin persisted up to one month and maintained the prominent hyperkeratosis
and gross architectural characteristic of HI (Fig 7A). However, the mutant skin did not main-
tain its early post-natal organization (Fig 7B). This was not unexpected as smsk skin has a
severe barrier dysfunction. Here we focused on whether the application of topical desquama-
tory enzymes could have an effect on SC thickness and cohesion of HI mutant skin. We applied
once daily either a Vaseline-based control cream or an identical cream formulated to contain
recombinant KLK 5 and -7 to HI grafts (Fig 7C). In the presence of the KLKs, the top layers of
HI grafts started to peel as early as 5 days after treatment, followed by obvious sloughing of the
hyperkeratotic SC 7 days after application of the enzymes (Fig 7C and 7D). In contrast, there
was no alteration in the appearance of the vehicle treated HI control samples (compare the
similar appearance of the smsk transplant in Fig 7A with d7 control treated smsk sample in Fig
7C). These experiments indicate that the smskmodel may be used in preclinical studies to pur-
sue novel therapies to ameliorate the severe skin defects of HI newborns.
Discussion
We have identified a novel mutation in Abca12 that elicits many of the features of HI, including
severe hyperkeratosis, LB defects, absence of intercellular lipid lamellae, aberrant protein pro-
cessing, defective lipid trafficking, limb contractures and the absence of skin barrier function.
Most importantly, this HI mouse model allowed us to uncover the pathophysiological basis for
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Fig 6. Inhibition of glucosylceramide productionmimics defects in KALLIKREIN secretion from
cultured Abca12smsk/smsk keratinocytes. (a) Secretion of KLKs into the culture media from cultured
keratinocytes were measured via ELISA. Basal levels of KLK5 and -7 were readily detected in the culture
media of keratinocytes grown under low Ca++ conditions, and this increased after differentiation induced by
elevated Ca++ levels (p<0.01 for both KLK5 and -7). Pre-treating WT keratinocytes with d,l-threo-1-phenyl-
2-decanoylamino-3-morpholino-1-propanolhydro-chloride (PDMP) significantly reduced secreted KLK5, -7
levels (p<0.05). Note that levels of KLKs in the media of Abca12smsk/smsk cells remained unaffected by Ca++
or PDMP treatment. Both KLK and protease activity in smsk keratinocytes were lower thanWT (**, p<0.05).
(b) Protease activity was measured in the conditioned media fromWT or Abca12smsk/smsk keratinocytes.
Similar to secreted KLK levels, protease activity in WT cells was elevated after Ca++ differentiation (p<0.05)
and suppressed by PDMP pretreatment. In contrast, protease activity in the cultured media remained
unaffected in Abca12smsk/smsk keratinocytes either after differentiation or PDMP treatment. Sample size n = 3
was used for each condition tested.
doi:10.1371/journal.pone.0161465.g006
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the severe desquamation defects observed in HI and test a novel therapeutic approach for treat-
ing HI and potentially other hyperkeratotic disorders.
One of the most pronounced features of HI is the striking hyperkeratosis of the epidermis.
A mechanistic understanding of this pathological feature of HI has remained elusive [30, 45].
In our studies, CDSN, whose deficiency has been implicated with flaky skin in humans [46]
Fig 7. Transplant of Abca12smsk/smsk skin grafts. (a) Back skins of E18.5 WT and Abca12smsk/smsk embryos were transplanted onto nude mice.
Bar = 2 mm. (b) Histological presentation of H&E stained sections of the grafts fromWT and smsk transplanted skin. Note the loss of normal epidermal
architecture at the end of 3 wks of transplantation in the smsk grafts. Bar = 50 μm. (c) Smsk E18.5 skin grafts were treated daily with a cream containing
either the recombinant KLKs or the digestion buffer (Control). Shedding of the top layers of the hyperkeratotic skin grafts was observed only in grafts
treated topically with KLK cream. Images were taken after 7 days of treatment. Bar = 2 mm. (d) Representative H&E images are shown of control and
KLK cream treated smskmutant skin grafts. Bar = 10 μm.
doi:10.1371/journal.pone.0161465.g007
A Novel Abca12Mutant Mouse Model of Harlequin Ichthyosis
PLOS ONE | DOI:10.1371/journal.pone.0161465 August 23, 2016 12 / 20
and mice [47], was markedly reduced in the Abca12smsk/smsk SC. However, it is clear that the
reduced levels of CDSN is secondary to the pronounced cohesion between corneocytes in
mutant skin and indicates that the maturation of desmosomes into CDs may also be defective.
The reduced lipid lamellar structures observed in the SC interstices of the mutant epidermis
contribute to the tight packing of corneocytes. Nevertheless, we present several lines of evi-
dence indicating that the hyperkeratosis observed in HI is likely caused by a severe defect in
desquamation. First, proliferative rates in basal layer keratinocytes were unaltered in
Abca12smsk/smsk skin, discounting enhanced proliferation as a cause for hyperkeratosis. Second,
corneocytes in Abca12smsk/smsk SC were highly resistant to chemical dissociation. Third, CDs
were retained in the SC of Abca12smsk/smsk epidermis, while desquamation enzymes KLK5 and
-7 were absent or reduced. Lastly, exogenous application of KLKs induced flaking in grafts
from Abca12smsk/smsk skin, which mimicks the normal process of desquamation. In support of
our findings, previous studies have shown defects in the delivery of proteolytic enzymes (e.g.,
KLK7) and other LB cargo proteins to the SC in human HI tissue [48, 49], and the secretion of
KLK5 is diminished in Abca12-null mouse keratinocytes [50]. Other groups have reported the
persistence of CDs in the distal layers of the epidermis in ABCA12 mutant mice [23, 25]. More-
over, mice deficient in INVOLUCRIN, ENVOPLAKIN, and PERIPLAKIN show barrier
defects, decreased desquamation, and hyperkeratosis that is concomitant with decreased KLK
activity [51]. These observations and our current findings strongly argue that HI is not simply
a defect caused by aberrant lipid trafficking, but also a disease of defective desquamation.
To address how defects in lipid trafficking may alter desquamation, we performed a series
of experiments to determine whether ABCA12 may be required for the transport of lipids and
KLKs. We showed that Cer and its metabolites (e.g., GlcCer) colocalized with KLKs in differen-
tiating keratinocytes and that inhibition of intracellular GlcCer production led to a reduction
in KLK accumulation in the media of cultured keratinocytes. These findings agree with previ-
ous studies that showed a strong link between lipid and enzyme accumulation in LBs [45]. Our
data indicate that ABCA12 may function to directly transport lipids, thereby providing LBs
with structural properties that enable the uptake and transport of KLKs. Alternatively,
ABCA12 might be independently required for the transport of both lipids and enzymes. Fur-
ther analysis will be required to distinguish between these possibilities. The Abca12smsk/smsk
mouse model results from a splice site mutation that causes exon skipping and loss of coding
sequences from the first ATP binding cassette. The smskmutant model, as is the case for previ-
ously described ABCA12 mutant mice [23–25] would be expected to act as a null mutation and
cause the severe skin phenotype seen in HI patients. Other mutations in ABCA12 result in the
less severe skin diseases, LI 2 and NBCIE [19, 20]. It will be important to determine whether
lipid and/or protein transport through LBs is also defective in these patients.
In HI, it is now apparent that loss of ABCA12 function prevents the transfer of lipids and
KLKs through the LBs, thus impairing both lipid barrier formation and desquamation. There-
fore, HI is not simply a disease of deregulated lipid metabolism in the epidermis, but also a dis-
ease of profound desquamation defects. Current treatments for HI and other diseases of the
ARCI spectrum include treatment with retinoids and skin softeners, but these are limited in
preventing disease progression. Therefore, we utilized the new pathogenic insights gained from
our Abca12smsk/smsk HI studies to test an alternative treatment strategy by the topical applica-
tion of enzymes involved in desquamation. We demonstrated that topical application of
recombinant KLKs can efficiently alleviate the severe hyperkeratosis that develops in trans-
planted HI mouse skin grafts. These results further strengthen our conclusion that the absence
of proteolytic enzymes is a major factor contributing to the pathogenesis of HI, and also sug-
gest that the topical application of desquamation enzymes may represent a novel therapeutic
strategy for the treatment of HI and potentially other hyperkeratotic disorders.
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Materials and Methods
Animal, DNA and RNA experiments
Animal experiments were approved by The University of Colorado Institutional Animal Care
and Use Committee (IACUC). The ENU screen was performed as previously described [52].
Heterozygous carriers were mated and the embryonic stages were determined by considering
noon of the day of a vaginal plug as E0.5. Embryonic skins were either directly embedded in
OCT followed by freezing on dry ice or fixation in 4% paraformaldehyde for paraffin process-
ing. RNA isolation and cDNA production were performed using standard techniques and as
previously described [53]. Abca12 cDNA fragments encompassing exons 28 to 31 (764bp)
were amplified by RT-PCR using the following oligos: forward– 5’- gtc ctg act gtg cat ttc cct cca
aca-3’, and reverse– 5’-ttc ttc ttg gtg agt gtg agg tgg ta-3’. PCR products were then resolved and
visualized on 1.2% agarose gel containing ethidium bromide. The cDNA fragments were iso-
lated and analyzed by dideoxy-sequencing. Abca12 expression was evaluated using Taqman
probe sets for Abca12 and Gapdh (Abca12:Mm00613683_m1; Gapdh:4351309). Klk7 expres-
sion was evaluated using Sigma Aldrich KiCqstart predesigned primers: Klk7-Fw: 5’-agg aga
aag gat tat aga tgg c -3’ & Klk7-Rv: 5’-ctt gct act gac cca ttt tg -3’). Cdsn expression was evalu-
ated using a predesigned Primetime probe through IDT (Mm.PT.58.6164239) and normalized
to the Taqman probe for Gapdhmentioned above. All assays were run on a Roche LightCy-
cler480 and fold change determined by the ΔΔCt method.
Immunofluorescence staining
Immunofluorescence was performed as previously described [53]. Sections were incubated
with antibodies against KRT -1, -8, -6, -14, and -16, FILAGGRIN, and LORICRIN [54], KLK5
(H-55; Santa Cruz Biotechnology, Dallas, Texas), KLK7 (H-50; Santa Cruz Biotechnology)
anti-GlcCer/Cer (RAS_0011; Glycobiotech, Bostel, Germany), anti-Desmoplakin (Fitzgerald;
Acton, MA), anti-DSC3 (U114; Progen; Heidelberg, Germany), anti-DSG1/2 (DG3.10; Pro-
gen), anti-Involucrin (M-116; Santa Cruz Biotechnology) and anti-CDSN (P-20; Santa Cruz
Biotechnology). The anti-GlcCer/Cer antisera shows cross-reactivity in both the SC and SG
[50, 55, 56]. Alexa-fluor conjugated secondary antibodies were purchased from Invitrogen. For
determination of proliferation index, pregnant mice were injected i.p. with BrdU (Invitrogen
-Thermo Fisher Scientific, Waltham, MA) and sacrificed 2h after injection. Embryos were har-
vested and processed for histology. Slides were stained with an anti-BrdU antibody (Invitro-
gen). Nuclei were counterstained with DAPI (Vector Laboratories, Burlingame, CA). Image
acquisition for all staining experiments was performed on a Nikon 90i microscope system
(Nikon Corporation, Tokyo, Japan)
Skin permeability assay and cornified envelope preparations
Toluidine blue dye penetration assays were performed as previously described [57]. CEs and
epidermal protein samples were prepared as previously reported without sonication steps [58].
Embryo skin pieces (0.25 cm2) were boiled at 95°C for 10 min in extraction buffer (0.01 M Tris
pH 7.4, 2% SDS, 100 mMNaCl, 5 mM EDTA pH 8.0).
Transmission Electron Microscopy
Mid-dorsum skins were processed for TEM as described with minor modifications [45, 59].
Briefly, all samples were postfixed in reduced 1% osmium tetroxide containing 1.5% ferrocya-
nide in 0.1 M cacodylate buffer followed by rinsing and en bloc staining in 2% aqueous uranyl
acetate. The samples then were dehydrated in a graded ethanol series and embedded in Epon.
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Sections were cut on a Leica Ultracut E and observed on a Zeiss 10A electron microscope (Carl
Zeiss Inc, Thornwood, NY) at 60 kV without further counterstaining.
Localization of labeled KALLIKREIN proteins and C5 ceramides in
primary cultures of mouse keratinocytes
Recombinant human KLK5 (R&D Systems, Minneapolis, MN) and KLK7 (Invitrogen) were
labeled with Alexa Fluor 488 Protein Labeling Kit per manufacturer’s instructions (Invitrogen).
Labeled KLKs were transfected into cultured WT keratinocytes using X-fect Protein Transfec-
tion Reagent (Clontech, Mountain View, CA) and then incubated with BODIPY TR- labeled
ceramides (Invitrogen). Cells were then cultured for 12h in 0.05mM Ca++, and then induced to
differentiate by increasing Ca++ levels in the media to 0.6mM.
Determination of secreted KALLIKREIN proteins and protease activity
from cultured keratinocytes
For these experiments, we used primary keratinocytes cultures grown in low and high calcium
conditions (see above). In KLK Elisa assays, 96-well plates (Corning, Corning, NY) were coated
with rabbit anti-KLK5 or KLK7 antibody (Santa Cruz Biotechnology) at 1 μg/ml in phosphate-
buffered saline (PBS). The wells were washed, blocked with PBS containing 1% BSA, and then
incubated for 3 h with media isolated from keratinocytes grown for 12 hours in fresh media.
Biotinylated goat anti-KLK5 or anti-KLK7 antibodies (R&D Systems) were used as detection
antibodies. Colorimetric quantification at 450 nm was carried out by incubating plates with
streptavidin-conjugated horseradish peroxidase (R&D Systems, Minneapolis, MN) and
3,305,50-tetramethylbenzidine substrate (BD Biosciences, San Jose, CA). The reactions were
stopped by 0.2 M sulfuric acid (Sigma-Aldrich, St. Louis, MO). The enzymatic activity of KLK
proteins was measured by an EnzChek Protease Assay Kit (green fluorescence, Invitrogen) fol-
lowing the manufacturer’s recommendations. Absorbance or fluorescence was measured on a
Glomax plate reader (Promega, Madison, WI)
Skin transplantation and KALLIKREIN treatment
Skin transplantation procedures were performed as described with modifications [60]. Briefly,
E18.5 back skin biopsies (>2.0 cm2) of Abca12smsk/smsk orWT embryos were transplanted onto the
back of nude mice under anesthesia (Isoflurane). Mice were treated with Carprofen [5 mg/kg]
prior to surgery and 24 hours post-surgery, totaling 48 hours of analgesia. The whole transplanted
area was covered with sterile dressing for 24h and then left uncovered for the duration of the exper-
iment. Mice were sacrificed using a high dose of Isoflurane in accordance with The University of
Colorado IACUC. Recombinant human KLK5 (R&D Systems) and KLK7 (Invitrogen) proteins
were diluted in the digestion buffer (100mM sodium phosphate, 0.1mM EDTA, pH 7.4.0) at work-
ing concentrations. KLKs were then formulated into a Vaseline-based cream by diluting KLKs into
1x digestion buffer at a final concentration of KLK5 [5ng/uL] and KLK7 [10ng/uL]. 1 mL of the
enzyme solution was combined with 1mL unscented Vaseline and vortexed at maximum speed for
1hr or until homogeneous. Starting from day 3 post-transplantation, the Abca12smsk/smsk skin grafts
were topically treated with cream containing KLK5 and -7, or the digestion buffer only as a control.
HI grafts were harvested after 7-21d of daily applications.
Statistics
Experiments were repeated independently at least twice with n = 3 replicates for each condi-
tion. A student’s t-test was used to determine significance using Graph pad Prism v.5 software.
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Supporting Information
S1 Fig. Retention of corneodesmosomes in Abca12smsk/smsk skin. (a) TEM of the SC was per-
formed on E18.5 WT and smskmutant skin samples. The image in WT shows the lower SC
and underlying granular layer (SG). The image of the mutant is at the same magnification as
the WT, showing the lower layers of the SC. Arrows denote CDs. In WT skin, CDs are evident
in the lower SC, the first two layers of SC closest to the SG. Bar = 1 μm. Note the persistence of
CDs throughout the smskmutant SC. Moreover, smskmutant skin exhibited incomplete
(delayed) cornification with corneocytes appearing transitional. Bar = 1 μm. (b) CD density
was quantified by counting the number of CDs per length of corneocyte membranes in the
field. Smsk skin had significantly more CDs than WT skin both in the lower and upper SC,
which verified the retention of CDs in mutant SC. The values shown represent the
average ± SD of 10 images from n = 3 embryos analyzed per genotype.
(TIF)
S2 Fig. Gene expression analysis of Kallikreins and Corneodesmosin in Abca12smsk/smsk skin.
qPCR analysis was performed on RNA isolated from E18.5 WT and smsk skin. Expression was
normalized to Gapdh. Abca12, Klk7 and Cdsn transcripts were significantly upregulated in
mutant samples.
(TIF)
S3 Fig. KALLIKREIN proteins colocalize with ceramide metabolites in differentiating kera-
tinocytes. (a) Recombinant KLK5 was labeled with Alexa 488 (green), and C5-ceramides with
Bodipy-TR (red), and were introduced into cultured WTmouse keratinocytes. Ceramides are
metabolized into GlcCer in keratinocytes. After inducing differentiation, KLK5 was extensively
co-detected with labeled lipids. Similar results were observed with KLK7 (not shown).
Bar = 10 μm. (b) Colocalization of labeled lipids and KLKs was determined by confocal micros-
copy. Images shown represent 1 micron steps covering the depth of a single stained keratino-
cyte. Note the merging of the green and red staining (yellow granules) in the images.
Bar = 5 μm.
(TIF)
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